rhenium has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacher, K; De Decker, M; De Vos, F; Dierckx, RA; Slegers, G; Thierens, H | 1 |
| Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R | 1 |
2 other study(ies) available for rhenium and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; CD52 Antigen; Cell Line; Chromatography, Thin Layer; Drug Stability; Glycoproteins; Humans; Isotope Labeling; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Quality Control; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation | 2003 |